Makers of Brainwave Optimization Technologies® and Cereset™ Announce New Clinical Trial for Mild-Traumatic Brain Injury

 Military personnel, athletes and accident victims who experience concussions can suffer from painful and debilitating conditions that impact everyday activities. Persisting symptoms from these mild Traumatic Brain Injuries (mTBI) can include sleep disturbance, anxiety, depression, foggy thinking, headaches, dizziness and behavioral issues.Continue reading

NuvOx Pharma’s NVX-208 Shows Positive Results in Phase Ib/II Stroke Trial

Positive results of NuvOx Pharma’s NVX-208 in the treatment of stroke have been published at the International Stroke Conference.  The trial was sponsored by the University of Arkansas for Medical Sciences. William “Bill” Culp, MD, the principal investigator on the trial, said, “Such strong safety and promising efficacy results meet our highest hopes for this small trial. Expanded trials are fully warranted.”Continue reading